Ufp Technologies UFPT
NASDAQ UFPT
$304.38 -8.46 (-2.70%)
As of: Aug 20, 2026 · 3:59 PM EDT

Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026)

Ufp Technologies' (UFPT) quarterly Liabilities and Shareholders Equity came in at $674.7 million in Q1 2026, up 4.99% YoY from $642.6 million in Q1 2025, and up 2.99% on a QoQ basis from $655.1 million in Q4 2025.

Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Ufp Technologies (UFPT) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $674.7 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 4.99% year-over-year to $674.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 12.21% YoY) and the FY2025 annual result came in at $655.1 million, up 4.15% from the prior year.
  • Liabilities and Shareholders Equity climbed to $674.7 million in Q1 2026, from $655.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $674.7 million in Q1 2026 to a low of $363.3 million in Q1 2022.
  • A 5-year average of $498.5 million and a median of $407.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 81.81% — and 2023, when it rose 0.74%.
  • Tracing UFPT's Liabilities and Shareholders Equity over 5 years: stood at $378.2 million in 2022, then gained by 6.86% to $404.1 million in 2023, then surged by 55.64% to $629.0 million in 2024, then gained by 4.15% to $655.1 million in 2025, then climbed by 2.99% to $674.7 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $674.7 million (Q1 2026), $655.1 million (Q4 2025), and $652.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 Ufp Technologies 2.34 Bn 2.33 Bn 50.92 Mn 681.91 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 681.91 Mn
Mar 31, 2026 674.68 Mn
Dec 31, 2025 655.08 Mn
Sep 30, 2025 652.82 Mn
Jun 30, 2025 634.66 Mn
Mar 31, 2025 642.64 Mn
Dec 31, 2024 629.00 Mn
Sep 30, 2024 638.51 Mn
Jun 30, 2024 422.40 Mn
Mar 31, 2024 407.68 Mn
Dec 31, 2023 404.14 Mn
Sep 30, 2023 399.81 Mn
Jun 30, 2023 397.99 Mn
Mar 31, 2023 390.78 Mn
Dec 31, 2022 378.19 Mn
Sep 30, 2022 388.32 Mn
Jun 30, 2022 395.05 Mn
Mar 31, 2022 363.35 Mn
Dec 31, 2021 334.13 Mn
Sep 30, 2021 220.69 Mn